Astellas Pharma US Inc. recalls
2 notices naming Astellas Pharma US Inc. as the recalling firm, since December 23, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Astellas Pharma US Inc.: Astagraf XL and 1 more
Hazard (FDA): Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
FDAMedicines
Astellas Pharma US, Inc. Issues Voluntary Nationwide Recall of One Lot of PROGRAF® 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL® 0.5mg (Tacrolimus Extended-Release Capsules) Because Bottles Shipped to U.S. May Contain Empty Capsules
Hazard (FDA): Bottles may contain empty capsules.
FDAMedicines